Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094398825> ?p ?o ?g. }
- W2094398825 endingPage "5369" @default.
- W2094398825 startingPage "5364" @default.
- W2094398825 abstract "Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel gated by ATP binding and hydrolysis at its nucleotide binding domains (NBD). The NBDs dimerize in a head-to-tail configuration, forming two ATP binding pockets (ABP) with the ATP molecules buried at the dimer interface. Previous studies have indicated that ABP2, formed by the Walker A and B motifs of NBD2 and the signature sequence of NBD1, is the site critical for the ATP-dependent opening of CFTR. The G551D mutation in ABP2, the third most common cystic fibrosis-associated mutation, abolishes ATP-dependent gating, resulting in an open probability that is ∼100-fold lower than that of wild-type channels. Interestingly, we found that the ATP analog N6-(2-phenylethyl)-ATP (P-ATP) increases G551D currents mainly by increasing the open time of the channel. This effect is reduced when P-ATP is applied together with ATP, suggesting a competition between ATP and P-ATP for a common binding site. Introducing mutations that lower the nucleotide binding affinity at ABP2 did not alter significantly the effects of P-ATP on G551D-CFTR, whereas an equivalent mutation at ABP1 (consisting of the Walker A and B motifs of NBD1 and the signature sequence of NBD2) dramatically decreased the potency of P-ATP, indicating that ABP1 is the site where P-ATP binds to increase the activity of G551D-CFTR. These results substantiate the idea that nucleotide binding at ABP1 stabilizes the open channel conformation. Our observation that P-ATP enhances the G551D activity by binding at ABP1 implicates that ABP1 can potentially be a target for drugs to bind and increase the channel activity." @default.
- W2094398825 created "2016-06-24" @default.
- W2094398825 creator A5023257350 @default.
- W2094398825 creator A5052024256 @default.
- W2094398825 creator A5082283281 @default.
- W2094398825 date "2008-02-01" @default.
- W2094398825 modified "2023-10-12" @default.
- W2094398825 title "Mechanism of G551D-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Potentiation by a High Affinity ATP Analog" @default.
- W2094398825 cites W1786021994 @default.
- W2094398825 cites W1977353319 @default.
- W2094398825 cites W1983488739 @default.
- W2094398825 cites W1986682462 @default.
- W2094398825 cites W1995579048 @default.
- W2094398825 cites W2004844038 @default.
- W2094398825 cites W2039599894 @default.
- W2094398825 cites W2043524902 @default.
- W2094398825 cites W2045331285 @default.
- W2094398825 cites W2047198892 @default.
- W2094398825 cites W2047384616 @default.
- W2094398825 cites W2052588826 @default.
- W2094398825 cites W2066266956 @default.
- W2094398825 cites W2079882135 @default.
- W2094398825 cites W2080423498 @default.
- W2094398825 cites W2094398863 @default.
- W2094398825 cites W2110652155 @default.
- W2094398825 cites W2112316338 @default.
- W2094398825 cites W2114007446 @default.
- W2094398825 cites W2114087686 @default.
- W2094398825 cites W2126532539 @default.
- W2094398825 cites W2128581282 @default.
- W2094398825 cites W2137704498 @default.
- W2094398825 cites W2139987902 @default.
- W2094398825 cites W2148598721 @default.
- W2094398825 cites W2161849629 @default.
- W2094398825 cites W2167724548 @default.
- W2094398825 cites W2189222387 @default.
- W2094398825 doi "https://doi.org/10.1074/jbc.m709417200" @default.
- W2094398825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18167357" @default.
- W2094398825 hasPublicationYear "2008" @default.
- W2094398825 type Work @default.
- W2094398825 sameAs 2094398825 @default.
- W2094398825 citedByCount "40" @default.
- W2094398825 countsByYear W20943988252015 @default.
- W2094398825 countsByYear W20943988252016 @default.
- W2094398825 countsByYear W20943988252017 @default.
- W2094398825 countsByYear W20943988252018 @default.
- W2094398825 countsByYear W20943988252019 @default.
- W2094398825 countsByYear W20943988252020 @default.
- W2094398825 countsByYear W20943988252021 @default.
- W2094398825 countsByYear W20943988252022 @default.
- W2094398825 countsByYear W20943988252023 @default.
- W2094398825 crossrefType "journal-article" @default.
- W2094398825 hasAuthorship W2094398825A5023257350 @default.
- W2094398825 hasAuthorship W2094398825A5052024256 @default.
- W2094398825 hasAuthorship W2094398825A5082283281 @default.
- W2094398825 hasBestOaLocation W20943988251 @default.
- W2094398825 hasConcept C104317684 @default.
- W2094398825 hasConcept C107824862 @default.
- W2094398825 hasConcept C113027372 @default.
- W2094398825 hasConcept C12554922 @default.
- W2094398825 hasConcept C141315368 @default.
- W2094398825 hasConcept C145822097 @default.
- W2094398825 hasConcept C181199279 @default.
- W2094398825 hasConcept C185592680 @default.
- W2094398825 hasConcept C194544171 @default.
- W2094398825 hasConcept C23265538 @default.
- W2094398825 hasConcept C2778428886 @default.
- W2094398825 hasConcept C2779564974 @default.
- W2094398825 hasConcept C501734568 @default.
- W2094398825 hasConcept C512185932 @default.
- W2094398825 hasConcept C55493867 @default.
- W2094398825 hasConcept C75578959 @default.
- W2094398825 hasConcept C86803240 @default.
- W2094398825 hasConceptScore W2094398825C104317684 @default.
- W2094398825 hasConceptScore W2094398825C107824862 @default.
- W2094398825 hasConceptScore W2094398825C113027372 @default.
- W2094398825 hasConceptScore W2094398825C12554922 @default.
- W2094398825 hasConceptScore W2094398825C141315368 @default.
- W2094398825 hasConceptScore W2094398825C145822097 @default.
- W2094398825 hasConceptScore W2094398825C181199279 @default.
- W2094398825 hasConceptScore W2094398825C185592680 @default.
- W2094398825 hasConceptScore W2094398825C194544171 @default.
- W2094398825 hasConceptScore W2094398825C23265538 @default.
- W2094398825 hasConceptScore W2094398825C2778428886 @default.
- W2094398825 hasConceptScore W2094398825C2779564974 @default.
- W2094398825 hasConceptScore W2094398825C501734568 @default.
- W2094398825 hasConceptScore W2094398825C512185932 @default.
- W2094398825 hasConceptScore W2094398825C55493867 @default.
- W2094398825 hasConceptScore W2094398825C75578959 @default.
- W2094398825 hasConceptScore W2094398825C86803240 @default.
- W2094398825 hasIssue "9" @default.
- W2094398825 hasLocation W20943988251 @default.
- W2094398825 hasOpenAccess W2094398825 @default.
- W2094398825 hasPrimaryLocation W20943988251 @default.
- W2094398825 hasRelatedWork W1632224638 @default.
- W2094398825 hasRelatedWork W1982625622 @default.
- W2094398825 hasRelatedWork W2035177679 @default.
- W2094398825 hasRelatedWork W2035589520 @default.